Results 21 to 30 of about 4,340 (169)
Pure red cell aplasia caused by Parvo B19 virus in a kidney transplant recipient
Parvo B19 is a single stranded DNA virus, which typically has affi nity for erythroid progenitor cells in the bone marrow and produces a severe form of anemia known as pure red cell aplasia.
A Baral +4 more
doaj +1 more source
Good's Syndrome with Pneumocystis Jiroveci Lymphadenitis and Pure Red Cell Aplasia [PDF]
Pneumocystis jiroveci lymphadenitis is a rare manifestation of extrapulmonary pneumocystosis. A case of recurrent infection with lymphadenitis caused by Pneumocystis jiroveci in a middle-aged patient is described.
Jintana - Srisompong, Torpong - Thongngarm, Popchai - Ngamskulrungroj, Ruchira - Ruangchira-urai, Adhiratha - Boonyasiri
doaj +1 more source
A case of pure red cell aplasia in a simultaneous kidney-pancreas transplant recipient on immunosuppressive therapy is reported here. The patient presented with anemia unresponsive to erythropoietin treatment.
Francesca Labbadia +4 more
doaj +1 more source
Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide
Pure red cell aplasia (PRCA) is a rare disorder characterized by marked erythroid hypoplasia with maturation arrest in the bone marrow. Secondary acquired PRCA may be associated with hematologic disorders.
Tomoki Ito +11 more
doaj +1 more source
Aggressive Systemic Mastocytosis in Association with Pure Red Cell Aplasia
Aggressive systemic mastocytosis (ASM) is characterized by mast cell accumulation in systemic organs. Though ASM may be associated with other hematological disorders, the association with pure red cell aplasia (PRCA) is rare and has not been reported ...
Dhauna Karam +3 more
doaj +1 more source
Clonal hematopoiesis in adult pure red cell aplasia
Idiopathic pure red cell aplasia (PRCA) and secondary PRCA associated with thymoma and large granular lymphocyte leukemia are generally considered to be immune-mediated.
Naohito Fujishima +22 more
doaj +1 more source
Lymphoma is a group of blood cancers that can appear in lymph nodes, blood, bone marrow, spleen, liver, or the central nervous system, which makes drug delivery and disease monitoring difficult. This review summarizes how nanomedicine technologies may improve targeted treatment and imaging, while carefully separating approved or guideline‐supported ...
Mohd Ahmar Rauf +5 more
wiley +1 more source
Gene therapy is revolutionizing treatment paradigms for haemoglobinopathies, establishing a translational framework for disorders that impact red blood cell development. In their paper, Joshi et al. describe the preclinical and early clinical landscape of gene therapies for non‐haemoglobinopathy erythroid disorders and highlight common thematic ...
Gaurav Joshi +3 more
wiley +1 more source
Clinical profile of pure red cell aplasia
Clinical and hematological profiles of twelve patients with Pure Red Cell Aplasia (PRCA) are described. It was more common in fifth decade and in males. Eight patients had mild upper respiratory tract infection, eight patients had indigenous drug intake ...
E A Ashok Kumar, S Banavali
doaj +1 more source
ABSTRACT Objectives Genetic rare diseases (GRDs), including chronic granulomatous disease, familial hemophagocytic lymphohistiocytosis, and congenital neutropenia, often require hematopoietic stem cell transplantation (HSCT) as the only curative option.
Bo Kyung Kim +6 more
wiley +1 more source

